Details of the Drug

General Information of Drug (ID: DM4RCZ7)

• Drug Name: Delolimogene mupadenorepvec
• Synonyms: LOAd703

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 1/2	[1]
Pancreatic cancer	2C10	Phase 1/2	[2]

• Drug Type: Oncolytic virus
• Cross-matching ID: TTD ID: D5V7XP
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04123470) A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma. U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT02705196) Phase I/IIa Trial Evaluating Safety of LOAd703, an Armed Oncolytic Adenovirus for Pancreatic Cancer. U.S.National Institutes of Health.